2BB score and signals
Anika Therapeutics Inc.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 60 | Moderate |
| Momentum | 45 | Stable |
| Financial strength | 55 | Normal |
| Quality | 92 | Very Strong |
| Risk | 25 | Low |
Company facts
| Headquarters | Bedford, Massachusetts, United States |
| Founded | 1983 |
| Employees | 235 |
| 52-week range | $8.67 – $22.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | 0.102 | — | $30.59M |
| 2026-10-29 | — | 0.0612 | — | $30.02M |
| 2026-07-29 | — | -0.0816 | — | $29.80M |
| 2026-04-29 | 0.27 | -0.1632 | $29.61M | $28.70M |
Related companies
